Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5997-53-5
2. 66lq48a9bt
3. Sodium;2-phenyl-3h-benzimidazole-5-sulfonate
4. 2-phenyl-1h-benzimidazole-5-sulfonic Acid Sodium Salt
5. Sodium 2-phenyl-5-benzimidazolesulfonate
6. 1h-benzimidazole-5-sulfonic Acid, 2-phenyl-, Monosodium Salt
7. Phenylbenzimidazole Sulfonic Acid Sodium Salt
8. 2-phenylbenzimidazole-5-sulfonic Acid Sodium Salt
9. Sodium 2-phenyl-1h-benzo[d]imidazole-5-sulfonate
10. 5(or 6)-benzimidazolesulfonic Acid, 2-phenyl-, Sodium Salt
11. 1h-benzimidazole-6-sulfonic Acid, 2-phenyl-, Sodium Salt (1:1)
12. Unii-66lq48a9bt
13. Ensulizole Sodium Salt
14. Schembl3173641
15. Dtxsid601021879
16. Ensulizole Sodium [who-dd]
17. Ensulizole Sodium Salt [mi]
18. Phenylbenzimidazole-5-sulfonate Sodium
19. Phenylbenzimidazole-5-sulphonate Sodium
20. 2-phenyl-5-benzimidazolsulfonate Sodium
21. Sodium Phenylbenzimidazole Sulfonate [inci]
22. Q27264002
23. Sodium 2-phenyl-1h-benzylimidazole-5-sulfonate
24. 2-phenyl-5-benzimidazolsulfonate Sodium [who-dd]
| Molecular Weight | 296.28 g/mol |
|---|---|
| Molecular Formula | C13H9N2NaO3S |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 296.02315761 g/mol |
| Monoisotopic Mass | 296.02315761 g/mol |
| Topological Polar Surface Area | 94.3 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 420 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
A UNII-66LQ48A9BT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of UNII-66LQ48A9BT, including repackagers and relabelers. The FDA regulates UNII-66LQ48A9BT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. UNII-66LQ48A9BT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A UNII-66LQ48A9BT supplier is an individual or a company that provides UNII-66LQ48A9BT active pharmaceutical ingredient (API) or UNII-66LQ48A9BT finished formulations upon request. The UNII-66LQ48A9BT suppliers may include UNII-66LQ48A9BT API manufacturers, exporters, distributors and traders.
UNII-66LQ48A9BT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of UNII-66LQ48A9BT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right UNII-66LQ48A9BT GMP manufacturer or UNII-66LQ48A9BT GMP API supplier for your needs.
A UNII-66LQ48A9BT CoA (Certificate of Analysis) is a formal document that attests to UNII-66LQ48A9BT's compliance with UNII-66LQ48A9BT specifications and serves as a tool for batch-level quality control.
UNII-66LQ48A9BT CoA mostly includes findings from lab analyses of a specific batch. For each UNII-66LQ48A9BT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
UNII-66LQ48A9BT may be tested according to a variety of international standards, such as European Pharmacopoeia (UNII-66LQ48A9BT EP), UNII-66LQ48A9BT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (UNII-66LQ48A9BT USP).
LOOKING FOR A SUPPLIER?
